Effect of N-acetylcysteine on chronic bronchitis exacerbations: a systematic review and meta-analysis
Cazzola M, Calzetta L, Page C, Jardim J, Chuchalin AG, Rogliani P
Published in European Respiratory Review
Methodology
Meta-analysis of randomised controlled trials of oral N-acetylcysteine in chronic bronchitis and COPD measuring exacerbation rate and respiratory symptoms.
Key Findings
N-acetylcysteine significantly reduced exacerbations in chronic bronchitis and COPD, with higher doses needed in patients with airway obstruction.
Conclusions
Mucolytic antioxidant therapy protects the respiratory tract from recurrent exacerbations.
Limitations
Heterogeneous doses; mostly European trials.
Supplements Studied
N-acetylcysteine significantly reduced exacerbations in chronic bronchitis and COPD
Outcomes Measured
N-acetylcysteine significantly reduced exacerbations in chronic bronchitis and COPD
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.